VLC-BIOCLINIC Program 2017

Logo VLC_Bioclinic

Schedule: From 28 july 2017 to 20 september 2017. Monday, tuesday, wednesday, thursday, friday, saturday and sunday at 00:00 to 23:59.

 

Place: Vicerectorat d’Investigació i Política Científica

 
Description:

It is open the submission period of applications for the third edition of the VLC-BIOCLÍNIC 2017 Program, whose main objective is to encourage collaborative actions of translational research and knowledge transfer between researchers of the University of Valencia and researchers/professionals of the Health Research Institute INCLIVA.

VLC-BIOCLINIC 2017 PROGRAM

Subprogram A. Grants to execute explorative actions for the formulation of innovation projects in cooperation UV-INCLIVA, with a budget of 40.000 € and it will be funded preparatory actions of new projects, maximum 4.000€/proposal.

Subprogram B. Grants to execute innovative collaborative projects, based on preliminary results or experiences, already corroborated and that show transfer potential to the health system, with a total budget of 40.000 € and it will be funded 10.000 €/proposal as maximum.

The submission period starts July 28 and it will be open until September 20, 2017, both days included.

SUBMISSION OF EXPRESSIONS OF INTEREST

Researchers interested in finding the most appropriate partner in the other entity, could complete the form of expressions of interest available in the website . The Research and Innovation Service of the UV and the OTRI of the INCLIVA will search among their researchers/professionals, providing the applicants with the contact details of the possible partners.

 
Organized by:

Vicerectorat d’Investigació i Política Científica. Servei d’Investigació i Innovació..

 

Contact: vlc-bioclinic@uv.es

 
More information:
 
This website uses proprietary and third-party cookies for technical purposes, traffic analysis and to facilitate insertion of content in social networks on user request. If you continue to browse, we consider that you are accepting its use. For more information please consult ourcookies policy